Article Information
History
- February 22, 2021.
Article Versions
- Version 1 (November 18, 2020 - 11:09).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Lucia Mangone1,
- Francesco Gioia1,
- Pamela Mancuso1,
- Isabella Bisceglia1,
- Marta Ottone1,
- Massimo Vicentini1,
- Carmine Pinto2 and
- Paolo Giorgi Rossi1,*
- 1Epidemiology Unit, Azienda USL-IRCCS di Reggio Emilia, Via Amendola 2, 42122 Reggio Emilia, Italy
- 2Medical Oncology Unit, Azienda USL-IRCCS di Reggio Emilia, Viale Risorgimento 80, 42123 Reggio Emilia, Italy
- ↵*Corresponding author:
Paolo Giorgi Rossi, Epidemiology Unit, Azienda USL-IRCCS di Reggio Emilia, Via Amendola 2, 42122 Reggio Emilia, Italy., e-mail: paolo.giorgirossi{at}ausl.re.it
Posted February 22, 2021.
Cumulative COVID-19 incidence, mortality, and prognosis in cancer survivors: a population-based study in Reggio Emilia, Northern Italy
